𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levetiracetam in patients with cortical myoclonus: A clinical and electrophysiological study

✍ Scribed by Pasquale Striano; Fiore Manganelli; Patrizia Boccella; Anna Perretti; Salvatore Striano

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
200 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Levetiracetam is a new antiepileptic agent that exerts antimyoclonic effects. We conducted an open‐label trial to evaluate the effect of levetiracetam in chronic cortical myoclonus of diverse etiologies and to determine whether levetiracetam affects electrophysiological findings. Sixteen patients, aged between 19 and 72 years, with refractory, chronic, cortical myoclonus were recruited. We assessed myoclonus severity with the Unified Myoclonus Rating Scale (UMRS). The electrophysiological study comprised jerk‐locked averaging, somatosensory evoked potentials (SEPs), and long loop reflex I. Levetiracetam was administered add‐on at a starting dose of 500 mg twice per day up to the target dose of 50 mg/kg/day. Patients were reevaluated clinically and electrophysiologically 2 weeks after the titration phase. Fourteen patients completed the trial. Posttreatment UMRS scores showed an improvement of myoclonus in all cases. Pretreatment, 9 patients had “giant” SEPs. Posttreatment, the amplitude of these SEPs was reduced by more than 50% in 3 of 9 patients, and the mean N20‐P25 amplitude was reduced significantly. Pre‐ and posttreatment SEP amplitude was not related to myoclonus severity or duration. Levetiracetam is a promising and a relatively easy‐to‐test antimyoclonic agent, which has the potential to improve significantly the patient's disability; however, its long‐term efficacy should be verified in larger controlled studies. © 2005 Movement Disorder Society

📜 SIMILAR VOLUMES

A neurophysiological study of myoclonus
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome
✍ Cecilia Marelli; Laura Canafoglia; Federica Zibordi; Claudia Ciano; Elisa Visani 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Mutations in the ϵ‐sarcoglycan (__SGCE__) gene have been associated with DYT11 myoclonus‐dystonia syndrome (MDS). The aim of this study was to characterize myoclonus in 9 patients with DYT11‐MDS presenting with predominant myoclonus and mild dystonia by means of neurophysiological techn

Electrophysiologic and histologic studie
Electrophysiologic and histologic studies in clinically unaffected muscles of patients with prior paralytic poliomyelitis
✍ Carlos A. Luciano; Kumaraswamy Sivakumar; Sidney A. Spector; Marinos C. Dalakas 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Macro-electromyography (macro-EMG) studies have provided important information about the size of the motor units and the degree of reinnvervation in clinically affected muscles of patients with a history of poliomyelitis and postpolio syndrome. The study of clinically unaffected muscles and correlat

Distinguishing SWEDDs patients with asym
Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study
✍ Petra Schwingenschuh; Diane Ruge; Mark J. Edwards; Carmen Terranova; Petra Katsc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract Approximately 10% of patients diagnosed clinically with early Parkinson's disease (PD) have normal dopaminergic functional imaging (Scans Without Evidence of Dopaminergic Deficit [SWEDDs]). An important subgroup of SWEDDs are those with asymmetric rest tremor resembling parkinsonian tre

Tomaculous neuropathy: A clinical and el
Tomaculous neuropathy: A clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p<11.2
✍ Anthony A. Amato; Gary S. Gronseth; Kevin J. Callerame; Kathleen S. Kagan-Hallet 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Tomaculous neuropathy is the descriptive term for the "sausagelike" swellings of myelin characteristic of hereditary neuropathy with liability to pressure palsies (HNPP). A 1.5-Mb deletion in chromosome 17pl1.2 is present in the majority but not all cases of HNPP. We reviewed the clinical and electr

Progressive sensory neuropathy in patien
Progressive sensory neuropathy in patients without carcinoma: A disorder with distinctive clinical and electrophysiological findings
✍ Dr. Michael D. Kaufman; Linton C. Hopkins; Barrie J. Hurwitz 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

## Abstract Seven patients with severe progressive impairment of kinesthetic sense, mild dysfunction of cutaneous sense, and sparing of motor function were examined during a 3‐year period. The clinical and electrophysiological findings are described in detail. None of these seven has had evidence o